[go: up one dir, main page]

BR9307689A - Oral compositions containing anti-plaque, anti-calculus agents - Google Patents

Oral compositions containing anti-plaque, anti-calculus agents

Info

Publication number
BR9307689A
BR9307689A BR9307689-4A BR9307689A BR9307689A BR 9307689 A BR9307689 A BR 9307689A BR 9307689 A BR9307689 A BR 9307689A BR 9307689 A BR9307689 A BR 9307689A
Authority
BR
Brazil
Prior art keywords
oral
agents
compositions
zinc
ions
Prior art date
Application number
BR9307689-4A
Other languages
Portuguese (pt)
Inventor
Ronald Earl Montgomery
Angela Marie Maddux
Matthew Edward Volpenhein
Vrinda Ramchandra Shanbhag
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9307689A publication Critical patent/BR9307689A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES ORAIS CONTENDO AGENTES ANTI-PLACA, ANTI-CáLCULO"<D>. Esta invenção envolve composições para o cuidado oral, compreendendo: (a) óxido de zinco ou nitrato de zinco; uma fonte de íons de citrato; e um ou mais agentes anti-cálculo contendo fósforo selecionados do grupo que consiste de pirofosfato, fosfonato, difostonato e polifosfatos condensados lineares farmaceuticamente aceitáveis da fórmula geral (P~ n~O~ (3n+1)~) ^ (n+2)- ^ onde n é um inteiro de 2 a 21; onde a razão molar dos íons de zinco:íons de citrato varia de cerca de 1:0,1 a cerca de 1:20; a razão molar dos íons de zinco:agentes anticálculo contendo fósforo varia de cerca de 1:1 a cerca de 1:20; e (b) um veículo oral tópico farmaceuticamente aceitável. Esta invenção também envolve métodos para o tratamento ou prevenção de placa dentária, cálculo, gengivite ou ma-hálito da cavidade oral, compreendendo a administração à cavidade oral de um homem ou outro animal de uma quantidade segura e eficaz destas composições.Invention Patent: <B> "ORAL COMPOSITIONS CONTAINING ANTI-PLATE, ANTI-CALCULATION AGENTS" <D>. This invention involves compositions for oral care, comprising: (a) zinc oxide or zinc nitrate; a source of citrate ions; and one or more phosphorus-containing anti-calculus agents selected from the group consisting of pharmaceutically acceptable linear condensed polyphosphates, phosphonate, dipostonate and the general formula (P ~ n ~ O ~ (3n + 1) ~) ^ (n + 2) - ^ where n is an integer from 2 to 21; where the molar ratio of zinc ions: citrate ions ranges from about 1: 0.1 to about 1:20; the molar ratio of zinc ions: phosphorus-containing anticalculating agents ranges from about 1: 1 to about 1:20; and (b) a pharmaceutically acceptable topical oral vehicle. This invention also involves methods for the treatment or prevention of dental plaque, calculus, gingivitis or bad breath from the oral cavity, comprising administering to the oral cavity of a man or other animal a safe and effective amount of these compositions.

BR9307689-4A 1992-12-18 1993-12-06 Oral compositions containing anti-plaque, anti-calculus agents BR9307689A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99333692A 1992-12-18 1992-12-18
US14877593A 1993-11-16 1993-11-16
PCT/US1993/011786 WO1994014406A1 (en) 1992-12-18 1993-12-06 Oral compositions containing antiplaque, anticalculus agents

Publications (1)

Publication Number Publication Date
BR9307689A true BR9307689A (en) 1999-08-31

Family

ID=26846148

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9307689-4A BR9307689A (en) 1992-12-18 1993-12-06 Oral compositions containing anti-plaque, anti-calculus agents

Country Status (11)

Country Link
EP (1) EP0675705A1 (en)
JP (1) JPH08504816A (en)
CN (1) CN1095262A (en)
AU (1) AU5739994A (en)
BR (1) BR9307689A (en)
CA (1) CA2151815A1 (en)
CZ (1) CZ156895A3 (en)
HU (1) HUT72042A (en)
MX (1) MX9400052A (en)
TR (1) TR27536A (en)
WO (1) WO1994014406A1 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302373A (en) * 1993-06-10 1994-04-12 Church & Dwight Co., Inc. Liquid mouthwash containing a particulate bicarbonate suspension
US5885556A (en) * 1996-01-11 1999-03-23 The Procter & Gamble Company Tartar control oral compositions
US6190644B1 (en) * 1996-11-21 2001-02-20 The Procter & Gamble Company Dentifrice compositions containing polyphosphate and monofluorophosphate
US6713049B1 (en) 1999-11-12 2004-03-30 The Procter & Gamble Company Oral compositions providing optimal surface conditioning
US6350436B1 (en) 1996-11-21 2002-02-26 The Procter & Gamble Company Method of reducing staining of stannous in dentifrice compositions
US5939052A (en) * 1996-11-21 1999-08-17 The Procter & Gamble Company Dentifrice compositions containing polyphosphate and fluoride
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6846478B1 (en) * 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
JPH11246376A (en) * 1998-02-27 1999-09-14 Sunstar Inc Composition for oral cavity
GB9810806D0 (en) * 1998-05-21 1998-07-22 Boots Co Plc Odour absorbing agent
US6447789B1 (en) * 1999-10-13 2002-09-10 Terrie E. Banks Facial cleanser and method of treating skin conditions
ES2350177T3 (en) 1999-11-12 2011-01-19 THE PROCTER &amp; GAMBLE COMPANY ORAL COMPOSITIONS CONTAINING STANNY IONS.
MXPA02004783A (en) 1999-11-12 2002-08-30 Procter & Gamble Improved dual phase stannous oral compositions.
US20040146466A1 (en) 1999-11-12 2004-07-29 The Procter & Gamble Company Method of protecting teeth against erosion
US10470985B2 (en) 1999-11-12 2019-11-12 The Procter & Gamble Company Method of protecting teeth against erosion
CA2431002A1 (en) * 2000-12-05 2002-06-13 Colgate-Palmolive Company Zinc containing dentifrice of reduced astringency
ES2606367T3 (en) * 2002-01-03 2017-03-23 The Procter & Gamble Company Stable oral compositions comprising casein and fluoride phosphopeptide complexes
JP2005139201A (en) * 2002-11-19 2005-06-02 Showa Yakuhin Kako Kk Agent for dissolving dental calculi and dental caries
EP1586312A4 (en) 2002-11-19 2007-02-14 Showa Pharm Chem Ind AGENT INTENDED TO DISSOLVE THE TARTAR AND THE DENTAL CARIES
JP3957293B2 (en) * 2003-01-27 2007-08-15 花王株式会社 Oral composition
DE10311171A1 (en) * 2003-03-12 2004-09-23 Henkel Kgaa Oral and dental care composition with antitartar, antiplaque and anti-discoloration action, containing cationic antibacterial agent, aza-cycloalkane-diphosphonic acid and xanthan gum or carboxymethyl cellulose
MY151134A (en) * 2005-12-21 2014-04-30 Colgate Palmolive Co Improved oral compositions comprising zinc citrate and / or tocopherol agents
ATE431128T1 (en) 2006-03-22 2009-05-15 Procter & Gamble ORAL COMPOSITIONS CONTAINING ZINC
US8298516B2 (en) * 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
GB0706787D0 (en) * 2007-04-05 2007-05-16 Glaxo Group Ltd Novel use
MX2010005130A (en) 2007-11-09 2010-08-04 Procter & Gamble Oral stannous compositions.
CN101292943B (en) * 2008-06-20 2010-04-14 陕西太和科技股份有限公司 Nanometer zinc oxide toothpaste
IN2012DN02657A (en) 2009-10-29 2015-09-11 Colgate Palmolive Co
TWI455728B (en) * 2010-01-14 2014-10-11 Colgate Palmolive Co Dentifrice compositions
SG183905A1 (en) 2010-03-31 2012-10-30 Colgate Palmolive Co Oral care composition
PL2519215T3 (en) 2010-03-31 2017-02-28 Colgate-Palmolive Company Oral care composition
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
RU2679416C2 (en) 2014-06-20 2019-02-08 Колгейт-Палмолив Компани Oral care compositions containing zinc, tin (ii) and fluoride ion sources
BR112017007639A2 (en) * 2014-10-24 2018-06-19 Colgate Palmolive Co preparation of zinc citrate and oral hygiene compositions containing zinc citrate
BR112017011994B1 (en) * 2014-12-16 2021-01-05 Colgate-Palmolive Company oral hygiene composition and use
AU2014415217B2 (en) * 2014-12-26 2018-11-29 Colgate-Palmolive Company Zinc phosphate complex
RU2692066C2 (en) * 2014-12-26 2019-06-20 Колгейт-Палмолив Компани Zinc phosphate complex
EP3223914B1 (en) * 2014-12-26 2020-05-06 Colgate-Palmolive Company Zinc phosphate complex
RU2690157C2 (en) * 2014-12-26 2019-05-31 Колгейт-Палмолив Компани Zinc phosphate complex for oral care
WO2016105433A1 (en) * 2014-12-26 2016-06-30 Colgate-Palmolive Company Personal care compositions with zinc phosphate active
MX2017007692A (en) * 2014-12-26 2017-10-27 Colgate Palmolive Co Personal care composition with zinc phosphate active.
US10813849B2 (en) * 2015-02-05 2020-10-27 University Of Maryland, Baltimore Rechargeable calcium phosphate-containing dental materials
CN113747948B (en) 2019-04-26 2023-12-15 宝洁公司 Reduce tooth discoloration from cationic antimicrobials
JP2022099625A (en) * 2020-12-23 2022-07-05 小林製薬株式会社 Composition for oral cavity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187288A (en) * 1975-01-28 1980-02-05 Colgate Palmolive Company Modified abrasive system for dentifrices
US4309409A (en) * 1975-12-22 1982-01-05 Stauffer Chemical Company Anti-corrosion formulation for toothpastes
DE2747852A1 (en) * 1977-10-26 1979-05-03 Colgate Palmolive Co Dentifrice with improved cleansing and polishing action - contg. abrasive agent together with zinc cpd. to reduce abrasion of dental enamel
AU1746088A (en) * 1987-06-12 1988-12-15 Unilever Plc Oral compositions
NZ232572A (en) * 1989-03-13 1991-11-26 Vipont Pharma Oral rinse composition containing a benzophenanthridine alkaloid extract from sanguinaria canadesis
US5000944A (en) * 1989-06-09 1991-03-19 Colgate-Palmolive Company Zinc-containing oral products with reduced astringency

Also Published As

Publication number Publication date
MX9400052A (en) 1994-07-29
HUT72042A (en) 1996-03-28
TR27536A (en) 1995-06-07
CZ156895A3 (en) 1996-01-17
HU9501778D0 (en) 1995-08-28
JPH08504816A (en) 1996-05-28
CN1095262A (en) 1994-11-23
WO1994014406A1 (en) 1994-07-07
AU5739994A (en) 1994-07-19
EP0675705A1 (en) 1995-10-11
CA2151815A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
BR9307689A (en) Oral compositions containing anti-plaque, anti-calculus agents
BR9307688A (en) Oral compositions containing anti-plaque, anti-calculus agents
DK0609606T3 (en)
BR9810312A (en) Pharmaceutical composition that has marked antitumor activity and / or reduced side effects containing an antitumor agent and a derivative of hydroxy acid
BR9806060A (en) Compound, pharmaceutical composition and processes to treat a patient suffering from a sick condition, to inhibit factor xa, and to inhibit thrombin formation.
AU1473792A (en) Treatment of periodontitis
BR9602874A (en) Oral antibacterial composition and process for the treatment and prevention of bacterial plaque buildup on teeth
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
KR910009273A (en) Pharmaceutical composition for treating gastrointestinal pain
ES2136167T3 (en) IDEBENONE COMPOSITIONS TO TREAT ALZHEIMER&#39;S DISEASE.
Finkelstein et al. Mechanical devices versus antimicrobial rinses in plaque and gingivitis reduction
FI933681A0 (en) ANTIMICROBIAL MEDEL
SE8904354D0 (en) A PHARMACEUTICAL COMPOSITION
KR890003390A (en) Treatment of osteoporosis and related disorders
CA2136825A1 (en) Quaternary Nitrogen-Containing Phosphonate Compounds, for Treating Abnormal Calcium and Phosphate Metabolism as Well as Dental Calculus and Plaque
ATE180669T1 (en) USE OF PREGNANDER DERIVATIVES TO TREAT TUMORS
ATE224692T1 (en) ORAL AND DENTAL CARE FOR SENSITIVE TEETH
RU94046117A (en) Sulfur-containing phosphonate compounds used for treatment of anomal calcium and phosphate metabolism, pharmaceutical compositions
BR9911962A (en) Oral composition that has increased anti-plaque efficiency, and, process for the treatment and prevention of the accumulation of plaque in the teeth.
WO2001068076A3 (en) D-enantiomer of dfmo and methods of use thereof for treating cancer
KR880009656A (en) Treatment or prophylaxis of local periodontal disease
Yaegaki et al. The effect of mouthwash on oral malodour production
EP0612246A4 (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones.
JPH03200718A (en) Anti-calculous composition
BR9803306A (en) Dental floss for tartar control

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 7/16; A61K 33/42; A61K 33/30.

Ipc: A61Q 11/00 (2006.01), A61K 8/24 (2006.01), A61K 8/

Ipc: A61Q 11/00 (2006.01), A61K 8/24 (2006.01), A61K 8/